These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 35135218)

  • 21. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
    Havervall S; Marking U; Greilert-Norin N; Ng H; Gordon M; Salomonsson AC; Hellström C; Pin E; Blom K; Mangsbo S; Phillipson M; Klingström J; Hober S; Nilsson P; Åberg M; Thålin C
    EBioMedicine; 2021 Aug; 70():103523. PubMed ID: 34391088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification.
    Fukumoto T; Iwasaki S; Fujisawa S; Hayasaka K; Sato K; Oguri S; Taki K; Nakakubo S; Kamada K; Yamashita Y; Konno S; Nishida M; Sugita J; Teshima T
    Int J Infect Dis; 2020 Sep; 98():16-17. PubMed ID: 32599282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China.
    Qi Z; Yu Y
    Curr Top Med Chem; 2020; 20(13):1137-1140. PubMed ID: 32394842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hunting severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): From laboratory testing back to basic research.
    Yang DM; Chang TJ; Wang ML; Tsai PH; Lin TH; Wang CT; Liang KH
    J Chin Med Assoc; 2020 Jun; 83(6):524-526. PubMed ID: 32502116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV).
    Bano S; Hameed A; Al-Rashida M; Iftikhar S; Iqbal J
    Curr Med Chem; 2021; 28(22):4484-4498. PubMed ID: 33109027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion.
    Cordes AK; Heim A
    J Clin Virol; 2020 Apr; 125():104305. PubMed ID: 32143123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Novel Coronavirus: A Bird's Eye View.
    Habibzadeh P; Stoneman EK
    Int J Occup Environ Med; 2020 Apr; 11(2):65-71. PubMed ID: 32020915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
    Prathiviraj R; Kiran GS; Selvin J
    Gene Rep; 2020 Sep; 20():100777. PubMed ID: 32835133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Real-Q 2019-nCoV and DaAn Gene 2019-nCoV polymerase chain reaction assays for the detection of SARS-CoV-2.
    Marembo T; Chimbunde P; Chipendo T; Munemo C; Manangazira P; Bangure D
    J Clin Lab Anal; 2022 Jan; 36(1):e24161. PubMed ID: 34882825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia.
    Chu DKW; Pan Y; Cheng SMS; Hui KPY; Krishnan P; Liu Y; Ng DYM; Wan CKC; Yang P; Wang Q; Peiris M; Poon LLM
    Clin Chem; 2020 Apr; 66(4):549-555. PubMed ID: 32031583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 and COVID-19: How much do we know?
    Wang M; Liao Z
    Acta Virol; 2020; 64(3):288-296. PubMed ID: 32985201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction to: 2019 Novel coronavirus: where we are and what we know.
    Cheng ZJ; Shan J
    Infection; 2021 Feb; 49(1):197. PubMed ID: 33210242
    [No Abstract]   [Full Text] [Related]  

  • 33. Correction: 2019 Novel coronavirus: where we are and what we know.
    Cheng ZJ; Shan J
    Infection; 2022 Dec; 50(6):1637. PubMed ID: 36030335
    [No Abstract]   [Full Text] [Related]  

  • 34. Applying fixed point methods and fractional operators in the modelling of novel coronavirus 2019-nCoV/SARS-CoV-2.
    Panda SK
    Results Phys; 2020 Dec; 19():103433. PubMed ID: 33042771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
    Kumar S; Maurya VK; Prasad AK; Bhatt MLB; Saxena SK
    Virusdisease; 2020 Mar; 31(1):13-21. PubMed ID: 32206694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.
    Lupia T; Scabini S; Mornese Pinna S; Di Perri G; De Rosa FG; Corcione S
    J Glob Antimicrob Resist; 2020 Jun; 21():22-27. PubMed ID: 32156648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: New insights on novel coronavirus 2019-nCoV/SARS-CoV-2 modelling in the aspect of fractional derivatives and fixed points.
    Panda SK; Atangana A; Nieto JJ
    Math Biosci Eng; 2022 Jan; 19(2):1588-1590. PubMed ID: 35135218
    [No Abstract]   [Full Text] [Related]  

  • 38. New insights on novel coronavirus 2019-nCoV/SARS-CoV-2 modelling in the aspect of fractional derivatives and fixed points.
    Panda SK; Atangana A; Nieto JJ
    Math Biosci Eng; 2021 Oct; 18(6):8683-8726. PubMed ID: 34814319
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.